![Avery Catlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avery Catlin
Direttore/Membro del Consiglio presso Corbus Pharmaceuticals, Inc.
Patrimonio netto: 69 426 $ in data 31/10/2024
Profilo
Avery W.
Catlin is currently the Director at Corbus Pharmaceuticals, Inc. and the Vice President at CuraGen Corp.
Previously, he served as the Independent Director at Provention Bio, Inc. from 2018 to 2023 and at Corbus Pharmaceuticals Holdings, Inc. from 2014 to 2024.
He also held the position of Chief Financial Officer at MediSense, Inc. and Repligen Corp.
from 1992 to 1996 and Chief Financial Officer & VP-Operations at Endogen, Inc. from 1996 to 1999.
From 2000 to 2008, he was the Chief Financial Officer, Secretary & SVP at AVANT Immunotherapeutics, Inc. and from 2011 to 2017, he served as the CFO, Secretary, Treasurer & Senior Vice President at Celldex Therapeutics, Inc. Mr. Catlin completed his undergraduate degree at the University of Virginia and holds an MBA from Babson College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/05/2024 | 4 350 ( 0.04% ) | 69 426 $ | 31/10/2024 |
Ultime notizie su Avery Catlin
Posizioni attive di Avery Catlin
| Società | Posizione | Inizio |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Avery Catlin
| Società | Posizione | Fine |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | 15/08/2024 |
| PROVENTION BIO, INC. | Direttore/Membro del Consiglio | 27/04/2023 |
| CELLDEX THERAPEUTICS, INC. | Direttore Finanziario/CFO | 30/06/2017 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Direttore Finanziario/CFO | 01/10/2008 |
Endogen, Inc.
 Endogen, Inc. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Endogen, Inc. is a company that specializes in producing reagents and immuno-assay test kits. The company is based in Cambridge, MA. Endogen was acquired by Perbio Science AB, part of Thermo Fisher Scientific, Inc. from September 24, 2003 on July 08, 1999 for $14.77 million. | Direttore Finanziario/CFO | 01/01/1999 |
Formazione di Avery Catlin
| University of Virginia | Undergraduate Degree |
| Babson College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| CELLDEX THERAPEUTICS, INC. | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Health Technology |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Endogen, Inc. is a company that specializes in producing reagents and immuno-assay test kits. The company is based in Cambridge, MA. Endogen was acquired by Perbio Science AB, part of Thermo Fisher Scientific, Inc. from September 24, 2003 on July 08, 1999 for $14.77 million. | Health Technology |
MediSense, Inc.
 MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
- Borsa valori
- Insiders
- Avery Catlin
